| Tran Huyen Thi Ly, MD | |
|
9101 N Central Expy, Suite 430, Dallas, TX 75231-5927 | |
| (214) 363-8889 | |
| (214) 363-9416 |
| Full Name | Tran Huyen Thi Ly |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 20 Years |
| Location | 9101 N Central Expy, Dallas, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053520296 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | M4311 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Park Lane Allergy And Asthma Center Pa | 8527155910 | 2 |
News Archive
Janssen-Cilag International NV (Janssen) announced today it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for ibrutinib for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL) or relapsed or refractory mantle cell lymphoma (MCL), two forms of blood cancer.
Scientists at Washington University School of Medicine in St. Louis have discovered what appears to be a potent stimulator of new bone growth. The finding could lead to new treatments for osteoporosis and other diseases that occur when the body doesn't make enough bone.
According to a latest study finding presented at the Infectious Diseases Society of America 49th Annual Meeting, patients with HIV were less likely to have routine screening for breast, cervical and colon cancer compared with patients without HIV.
A paper published yesterday in Science Translational Medicine reports that the root cause of asthma has been found and a potential treatment to reverse all symptoms has been proposed...
› Verified 3 days ago
| Entity Name | Park Lane Allergy And Asthma Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851586994 PECOS PAC ID: 8527155910 Enrollment ID: O20081016000372 |
News Archive
Janssen-Cilag International NV (Janssen) announced today it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for ibrutinib for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL) or relapsed or refractory mantle cell lymphoma (MCL), two forms of blood cancer.
Scientists at Washington University School of Medicine in St. Louis have discovered what appears to be a potent stimulator of new bone growth. The finding could lead to new treatments for osteoporosis and other diseases that occur when the body doesn't make enough bone.
According to a latest study finding presented at the Infectious Diseases Society of America 49th Annual Meeting, patients with HIV were less likely to have routine screening for breast, cervical and colon cancer compared with patients without HIV.
A paper published yesterday in Science Translational Medicine reports that the root cause of asthma has been found and a potential treatment to reverse all symptoms has been proposed...
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tran Huyen Thi Ly, MD 9101 N Central Expy, Suite 430, Dallas, TX 75231-5927 Ph: (214) 363-8889 | Tran Huyen Thi Ly, MD 9101 N Central Expy, Suite 430, Dallas, TX 75231-5927 Ph: (214) 363-8889 |
News Archive
Janssen-Cilag International NV (Janssen) announced today it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for ibrutinib for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL) or relapsed or refractory mantle cell lymphoma (MCL), two forms of blood cancer.
Scientists at Washington University School of Medicine in St. Louis have discovered what appears to be a potent stimulator of new bone growth. The finding could lead to new treatments for osteoporosis and other diseases that occur when the body doesn't make enough bone.
According to a latest study finding presented at the Infectious Diseases Society of America 49th Annual Meeting, patients with HIV were less likely to have routine screening for breast, cervical and colon cancer compared with patients without HIV.
A paper published yesterday in Science Translational Medicine reports that the root cause of asthma has been found and a potential treatment to reverse all symptoms has been proposed...
› Verified 3 days ago
Matthew Frank Feldman, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 7557 Rambler Rd Ste 400, Dallas, TX 75231 Phone: 214-347-7337 | |
Nastaran Safdarian, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 8220 Walnut Hill Ln, Suite 101, Dallas, TX 75231 Phone: 214-369-1901 | |
Mr. Gary Neil Gross, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 5499 Glen Lakes Drive, Ste 100, Dallas, TX 75231 Phone: 214-691-1330 Fax: 214-691-6405 | |
Erin Elizabeth Clarke, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 8201 Preston Rd Ste 275, Dallas, TX 75225 Phone: 469-310-3681 Fax: 214-238-8084 | |
Dr. Sonak B Daulat, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 10216 Garland Rd, Dallas, TX 75218 Phone: 214-328-3232 | |
Dr. Sandeep Gupta, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 8220 Walnut Hill Ln, Suite 101, Dallas, TX 75231 Phone: 214-369-1901 Fax: 214-369-1905 |